MAUDE Adverse Event Report: MAGELLAN DIAGNOSTICS, INC. LEADCARE ULTRA CONSUMABLE; LEADCARE ULTRA,

Model Number	70-8090
Medical Device Problem Code	Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code	No Known Impact Or Consequence To Patient (2692)
Date of Event	08/13/2014
Type of Reportable Event	Malfunction
Additional Manufacturer Narrative
Mdr 1218996-2017-00035 addendum.User notified magellan to indicate results were "not matching up".The dates for these tests are on or around (b)(6) 2014.Patient 1 (sample 1): on leadcare ultra analyzer [not reportable].Samples run immediately after preparation in treatment reagent, in ug/dl: 3.2.Sample results after being held in treatment reagent for 72 hrs and tested, in ug/dl: 7.7.Patient 1 (sample 2): on leadcare ultra analyzer [not reportable].Samples run immediately after preparation in treatment reagent, in ug/dl: 3.2.Sample results after being held in treatment reagent for 1hr and tested, in ug/dl: 6.6.Patient 1 (sample 3): on leadcare ultra analyzer [not reportable].Samples run immediately after preparation in treatment reagent, in ug/dl: 3.2.Sample results after being held in treatment reagent for 1hr and tested, in ug/dl: 6.6.After further investigation, it has been determined that the reported blood lead sample.Data above was produced by the leadcare.Ultra instrument only.The samples were never re-tested using a standard reference method to get a "true" sample level, as a result there was no confirmation as to the inacuracy of the results and in accordance with our mdr decision tree these results would not be considered reportable.Same device kit from customer could not be used.The lot 1312bu materials were from magellan inventory.The customer's inventory was exhausted.Late filing is part of magellan diagnostics, inc.Response to fda's 483 issued on 29jun2017.Complaint # (b)(4).
Event or Problem Description
Mdr 1218996-2017-00035 addendum.Customer reported samples tested immediately after addition to treatment reagent produce lower blood lead values than when they are allowed to sit for 1 hour, 24 hours, or 72 hours in the treatment reagent before testing.

• Brand Name: LEADCARE ULTRA CONSUMABLE
• Common Device Name: LEADCARE ULTRA,
• Manufacturer (Section D): MAGELLAN DIAGNOSTICS, INC.; 101 billerica ave.; building 4; n. billerica MA 01862
• MDR Report Key: 9356620
• Report Number: 1218996-2019-00041
• Device Sequence Number: 13573009
• Product Code: DOF
• UDI-Device Identifier: 00850355006024
• UDI-Public: 00850355006024
• Combination Product (Y/N): N
• Initial Reporter State: MD
• Initial Reporter Country: US
• PMA/510(K) Number: K123563
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Reporter Type: Manufacturer
• Report Source: health professional
• Initial Reporter Occupation: Other Health Care Professional
• Type of Report: Initial
• Report Date (Section B): 11/21/2019

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 06/30/2015
• Device Model Number: 70-8090
• Device Catalogue Number: 70-8090
• Device Lot Number: 1312BU
• Was Device Available for Evaluation?: No
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 08/13/2014
• Initial Report FDA Received Date: 11/21/2019
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Patient Sequence Number: 1